Vaccitech (VACC) announced the appointment of Nadege Pelletier, Ph.D., as Chief Scientific Officer, CSO. Dr. Pelletier is stepping into the role formerly held by Tom Evans, Ph.D., who is retiring but will remain involved as a scientific consultant to the company. Dr. Pelletier joins Vaccitech from the Novartis Institutes for Biomedical Research and prior to that Roche (RHHBY) Pharma Research & Early Development, where she served as Project Leader in the fields of autoimmunity, inflammation and infectious diseases.
Published first on TheFly
